Caplin Point Targets High Double-digit US Growth with 14-15 Injectable Lines by FY27-28
Moneylife Digital Team 02 March 2026
Caplin Point Laboratories (Caplin), a mid-sized pharmaceuticals enterprise, has distinguished itself through a diversified business model spanning finished formulations, active pharmaceutical...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback